MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
about
Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and CisplatinIGF1R depletion facilitates MET-amplification as mechanism of acquired resistance to erlotinib in HCC827 NSCLC cells.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Targeting the tumor-promoting microenvironment in MET-amplified NSCLC cells with a novel inhibitor of pro-HGF activation.Characterization of epithelial-mesenchymal transition intermediate/hybrid phenotypes associated to resistance to EGFR inhibitors in non-small cell lung cancer cell lines.Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) - Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy.ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.Tis21-gene therapy inhibits medulloblastoma growth in a murine allograft model.Exosome-mediated transfer of lncRNA RP11‑838N2.4 promotes erlotinib resistance in non-small cell lung cancer.Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
P2860
Q28552029-A0C79FE7-4531-4BEA-ACDF-FE4BB40E4CD5Q38707122-7DD2AF33-33C3-4AFB-AA27-347B9212680AQ38729111-F2FBBC93-0701-4FE0-BCD1-39ABB3994300Q41825773-FE82F9C6-9AA4-4EAA-9EDC-754D02B7E041Q47154025-9AD5301F-0628-4931-B85F-CB92DA418438Q47261688-A7A24C14-6631-41E8-BCE7-1B0D16313734Q47433240-72B464F6-9672-4A67-AB42-4FF884D04713Q49887903-B32C6C1C-2EDC-40D5-8EC1-B3117D422C7AQ54256077-3CD77761-5F9F-4D81-84D6-4A48400EF040Q54977761-3410AABA-E9F9-4AED-9DC5-662061EA1BB2Q58786408-DE50E965-2D4C-4BFC-8F86-C93F81FDAC4F
P2860
MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@ast
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@en
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@nl
type
label
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@ast
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@en
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@nl
prefLabel
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@ast
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@en
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@nl
P2093
P2860
P50
P3181
P1433
P1476
MET Gene Amplification and MET ...... EGFR TKI-Resistant NSCLC Cells
@en
P2093
Cristiana Lalli
Giuseppe Giannini
Simone Samperna
Simonetta Santini
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0143333
P407
P577
2015-01-01T00:00:00Z